EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression

Mira B Cladder-Micus, Janna N Vrijsen, Antine Fest, Jan Spijker, A Rogier T Donders, Eni S Becker, Anne E M Speckens

Journal of Affective Disorders · 2023-08 · 335 · 410-417

DOI: 10.1016/j.jad.2023.05.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023-08. Verfasst von Mira B Cladder-Micus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Depression Expertise Centre, Pro Persona Mental Health Care, the Netherlands; Behavioural Science Institute, Radboud University Nijmegen, the Netherl…. Hauptthemen laut MEDLINE: Mindfulness, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mindfulness-based cognitive therapy (MBCT) is an evidence-based treatment for depression. The current study focused on the long-term outcomes of MBCT for chronically, treatment-resistant depressed patients during a 6-months follow-up period. Additionally, predictors of treatment outcomes were explored. METHOD: The outcomes of MBCT on depressive symptoms, remission rates, quality of life, rumination, mindfulness skills and self-compassion were investigated in a cohort of chronically, treatment-resistant depressed outpatients (N = 106), who had taken part in an RCT comparing MBCT with treatment-as-usual (TAU). Measures were assessed pre-MBCT, post-MBCT, at 3-months follow-up, and at 6-months follow-up. RESULTS: Results of linear mixed effect models and Bayesian repeated measures ANOVA's reveal that depressive symptoms, quality of life, rumination, mindfulness skills and self-compassion consolidated during follow-up. Remission rates even further increased over the course of follow-up. When controlling for symptoms at baseline, higher baseline levels of rumination predicted lower depressive symptoms and quality of life at 6-month follow-up. No other predictors (i.e. duration of current depressive episode, level of treatment-resistance, childhood trauma, mindfulness skills, self-compassion) were found. LIMITATIONS: All participants received MBCT, therefore time or other non-specific effects might have influenced the results and replication studies including a control conditions are needed. CONCLUSIONS: Results indicate that the clinical benefits of MBCT for chronically, treatment-resistant depressed patients persist up to 6 months after completing MBCT. Duration of the current episode, level of treatment-resistance, childhood trauma and baseline levels of mindfulness skills and self-compassion did not predict treatment outcome. When controlling for baseline depressive symptoms participants with high levels of rumination seem to benefit more; however more research is needed. TRIAL REGISTRY: Dutch Trial Registry, number NTR4843.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MindfulnessCognitive Behavioral TherapyHumansDepressionFollow-Up StudiesQuality of LifeBayes TheoremTreatment Outcome

Stichwörter der Autor:innen

Chronic depressionMindfulness-based cognitive therapyRuminationTreatment-resistant depression

Autor:innen und Institutionen

  • Depression Expertise Centre, Pro Persona Mental Health Care, the Netherlands; Behavioural Science Institute, Radboud University Nijmegen, the Netherlands. Electronic address: m.cladder-micus@propersona.nl.
  • Depression Expertise Centre, Pro Persona Mental Health Care, the Netherlands; Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, the Netherlands.
  • Department of Psychiatry, Radboud university medical center, the Netherlands.
  • Depression Expertise Centre, Pro Persona Mental Health Care, the Netherlands; Behavioural Science Institute, Radboud University Nijmegen, the Netherlands.
  • Department for Health Evidence, Radboud University Medical Center, the Netherlands.
  • Behavioural Science Institute, Radboud University Nijmegen, the Netherlands.

Zitieren

APA

Cladder-Micus, M. B., Vrijsen, J. N., Fest, A., Spijker, J., Donders, A. R. T., Becker, E. S., & Speckens, A. E. M. (2023). Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression. Journal of Affective Disorders, 335, 410-417. https://doi.org/10.1016/j.jad.2023.05.023

Vancouver

Cladder-Micus MB, Vrijsen JN, Fest A, Spijker J, Donders ART, Becker ES, et al. Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression. Journal of Affective Disorders. 2023;335:410-417. doi:10.1016/j.jad.2023.05.023

BibTeX
@article{CladderMicus2023,
  author = {Cladder-Micus, Mira B and Vrijsen, Janna N and Fest, Antine and Spijker, Jan and Donders, A Rogier T and Becker, Eni S and Speckens, Anne E M},
  title = {Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression},
  journal = {Journal of Affective Disorders},
  year = {2023},
  volume = {335},
  pages = {410--417},
  doi = {10.1016/j.jad.2023.05.023}
}
Kostenlos starten →